Clinical Trials Browser

Head and Neck Squamous Cell Cancer × Radiotherapy, Intensity-Modulated × Clear all

NCT02282371 2021-10-26

Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)

Phase 1 Completed

Head and Neck Squamous Cell Cancer